IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
$628,343N01FY2015CANIH
University Of Oklahoma Hlth Sciences Ctr, Oklahoma City OK
Investigators
Abstract
This Task Order will address the hypothesis that NSC 721689 can prevent high-grade serous ovarian cancer via mortalin binding.
View original record on NIH RePORTER →